Company news

CorMedix Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update

November 9, 2022

CorMedix Inc. Announces CMS Revision to NTAP Reimbursement of DefenCath

November 6, 2022

CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10

November 1, 2022

CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference

October 19, 2022

CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update

August 10, 2022

CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11

July 31, 2022

CorMedix to Participate at the JMP Securities Life Sciences Conference

June 7, 2022

CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

May 11, 2022

CorMedix Inc. Announces Leadership Updates and Operational Changes

May 11, 2022

CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12

May 2, 2022

CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline Development

April 6, 2022

CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference

April 3, 2022

CorMedix Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

March 28, 2022

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results and Provide a Corporate Update on March 29

March 21, 2022

CorMedix Inc. Announces the Appointment of Chief Executive Officer

March 16, 2022

Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath

February 27, 2022

CorMedix to Participate in Upcoming January Conferences

January 3, 2022

CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

November 8, 2021

CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9

November 1, 2021

CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI

October 19, 2021

CorMedix Inc. Announces Executive Leadership Changes

October 3, 2021

CorMedix Inc. Announces Regulatory Update

September 6, 2021

CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

August 11, 2021

CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12

July 27, 2021

CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

June 9, 2021

CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference

June 8, 2021

CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference

May 26, 2021

CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

May 12, 2021

CorMedix Inc. Announces Appointment of Chief Commercial Officer

May 12, 2021

CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13

May 4, 2021

CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit

April 27, 2021

CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA

April 13, 2021

CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference

April 6, 2021

CorMedix Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

March 29, 2021

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30

March 22, 2021

CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

March 14, 2021

CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt as Executive Vice President and Head of Clinical Operations

March 10, 2021

CorMedix Inc. to Host Regulatory Update Conference Call

March 7, 2021

CorMedix Receives Complete Response Letter From FDA for DefenCath™ Catheter Lock Solution

February 28, 2021

CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange

January 20, 2021

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

November 17, 2020

CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

November 4, 2020

CorMedix Appoints Greg Duncan to its Board of Directors

November 1, 2020

CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on November 5

October 28, 2020

CorMedix to Participate in BIO Investor Forum Digital

October 7, 2020

CorMedix Appoints Paulo Costa to its Board of Directors

September 16, 2020

CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September 8, 2020

CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath

August 30, 2020

CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update

August 9, 2020

CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10

August 2, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 28 decks. Every deck is listed under its year.